A new study demonstrates that those with terminal cancer do not necessarily benefit from chemotherapy. In fact, the results show just the opposite can occur.
The closer the cancer patient is to death’s door, the more likely that chemotherapy will accelerate the dying process, as well as considerably affect their quality of life for the worse. The better their quality of life, the more it will be eroded by the ravages of chemotherapy.
The older the cancer patient the more compromised the immune system, which then makes the individual more susceptible to all sorts of secondary infections and opportunistic pathogens. By administering chemo to the elderly with terminal cancer, the body’s natural defenses are simply overwhelmed. Oncologists have observed this phenomenon for decades. Nonetheless, hospital cancer patients are routinely administered their chemo regardless of these significant factors.